Cagrilintide vs tirzepatide (Mounjaro/Zepbound) Mechanism: Cagrilintide: Amylin agonist Tirzepatide: Dual GIP/GLP-1 agonist Both novel approaches Weight loss: Cagrilintide: 10-12% monotherapy Tirzepatide: 15-22% monotherapy Tirzepatide superior as single agent Administration: Both: Weekly subcutaneous injection Both: Similar convenience Side effects: Cagrilintide: Strong GI effects Tirzepatide: Moderate GI effects Similar overall profile Approval status: Cagrilintide: Investigational Tirzepatide: FDA approved Tirzepatide available now Cost (when both available): Likely similar ($1,000-1,500/month) Both premium weight loss options Verdict: Currently, tirzepatide better choice (approved, superior weight loss)
Our care is in-house, never remote telemedicine, and every patient meets with real providers face to face
Advise patients to consult with their physician for a gradual discontinuation dose schedule to taper off the medication
Targeted Amino Acids (Taurine, L-Arginine, L-Carnitine) Taurine: Supports intracellular calcium regulation, which affects muscle contraction and excitability
Most users complete 2 to 3 cycles per year for ongoing maintenance
Lets break this down with evidence-backed highlights from peer-reviewed studies: BPC-157 has been shown to preserve and protect the mucosal lining of the stomach and intestines, especially in models of ulcers and colitis